TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria

Journal of Immunology

Volumn 165, Issue 10, 2000, Pages 5612-5620

  Thomas, W D ^a   Zhang, X D ^a   Franco, A V ^a   Nguyen, T ^a   Hersey, P ^a  

^a David Maddison Building ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; FAS LIGAND; RHODAMINE 123; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME RELEASE; HUMAN; HUMAN CELL; MELANOMA; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0034670025     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.10.5612     Document Type: Article

References (48)

1. Identification and characterization of a new member of the TNF family that induces apoptosis
2. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
3. TRAIL: A molecule with multiple receptors and control mechanisms
4. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells
5. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
6. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
7. 2 ligand: A novel lethal weapon against malignant glioma?
8. TRAIL (Apo-2L) and TRAIL receptors in human placentas: Implications for immune privilege
9. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
10. Safety and antitumor activity of recombinant soluble Apo2 ligand
11. How TRAIL kills cancer cells, but not normal cells
12. The CARD domain: A new apoptotic signalling motif
13. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA
14. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction
15. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB
16. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
17. Cell suicide for beginners
18. Mitochondrial control of apoptosis
19. A cellular poison cupboard
20. Mitochondrial release of caspase-2 and -9 during the apoptotic process
21. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis
22. A caspase-activated factor (CAF) induces mitochondrial membrane depolarization and cytochrome c release by a nonproteolytic mechanism
23. TRAIL causes cleavage of Bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells
24. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-X(L) prevents this release but not tumor necrosis factor-R1/Fas death
25. Two CD95 (APO-1/Fas) signaling pathways
26. Insights from Bcl-2 and Myc: Malignancy involves abrogation of apoptosis as well as sustained proliferation
27. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
28. Chemotherapy-induced apoptosis in melanoma
29. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma
30. Functional analysis of TRAIL receptors using monoclonal antibodies
31. Inhibition of interleukin 1 β-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP
32. Detection of intracellular cytokines by flow cytometry
33. Analysis of flow cytometry data
34. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
35. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives
36. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release
37. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells
38. Induction of polyploidy and apoptosis after exposure to high concentrations of the spindle poison nocodazole
39. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems
40. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis
41. Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis
42. Inhibition of human caspases by peptide-based and macromolecular inhibitors
43. Caspase-9 regulates cisplatin-induced apoptosis in human head and neck squamous cell carcinoma cells
44. Differential requirement for caspase-9 in apoptotic pathways in vivo
45. Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized
46. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region
47. Bcl-2 and mitochondrial oxygen radicals: New approaches with reactive oxygen species-sensitive probes
48. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases